Bank of America analysts on Friday said Novo Nordisk may miss first-quarter expectations, as sales of its blockbuster Wegovy ...

Novo Nordisk has quickly expanded its discounted Wegovy program, now offering all eligible cash-paying customers its popular weight-loss med at $499 per month. Novo had only launched the cheaper ...

Novo Nordisk NVO announced an update to the savings offer for its popular obesity injection, Wegovy (semaglutide). This update allows cash-paying patients or those with commercial insurance ...

March 24 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Monday all eligible cash-paying customers in the United States can buy its weight-loss drug Wegovy at a discounted price of $499 ...

Popular weight loss drug Wegovy, from the same company that makes the Ozempic diabetes treatment, is expected to be available in Ireland from Monday. Wegovy works by suppressing people’s ...

Novo Nordisk has updated its Wegovy savings program, allowing eligible cash-paying patients to access the drug at retail pharmacies for a reduced cost of $499 per month.

German business-software group SAP claimed the top spot as Europe's largest company by market value, dethroning Danish pharmaceutical giant Novo Nordisk. SAP shares in Frankfurt rose more than 0.5 ...

Wegovy, an injected drug used to treat obesity, will become available in ­pharmacies in Ireland from today on private prescription. The lowest dose of 0.25g will cost around €200 for a month ...